can i take semaglutide if i have high blood pressure Changes on 10 Popular GLP-1s and What To Expect Semaglutide and blood pressure: an

Wegovy Data as Reported by Novo Nordisk The manufacturers language on the weight loss indication reads thus: Wegovy (semaglutide) injection 2.4 mg is indicated in combination with a reduced-calorie diet and increased physical activity: to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged 12 years and older with obesity and adults with overweight in the presence of at least one weight-related comorbidity. At two years, patients taking Wegovy showed a mean weight loss of 15% or 34 pounds, from a mean baseline BMI of 38.5

Semaglutide group patients taking the maintenance dose of 2.4 mg achieved weight loss of 14.99% of initial body weight over the 68-week clinical trial

The decision should be made with the guidance of a healthcare provider

Individuals struggling with weight management or those interested in a more effective, personalized approach to weight loss are encouraged to schedule a consultation